Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding
Authors:
- Ayinuer AdijiangAAAyinuer Adijiang
- Matthew MahMMMatthew Mah
- Da-Wei ZhangDZDa-Wei Zhang
Open Access
- 1 December 2013
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 54 (12) , 3345-3357
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- A Two-step Binding Model of PCSK9 Interaction with the Low Density Lipoprotein ReceptorJournal of Biological Chemistry, 2011
- Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 CellsJournal of Biological Chemistry, 2009
- Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial diseaseAtherosclerosis, 2009
- Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptorProceedings of the National Academy of Sciences, 2008
- Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primatesProceedings of the National Academy of Sciences, 2008
- Molecular basis for LDL receptor recognition by PCSK9Proceedings of the National Academy of Sciences, 2008
- Molecular biology of PCSK9: its role in LDL metabolismTrends in Biochemical Sciences, 2007
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9Proceedings of the National Academy of Sciences, 2005
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003